FORA Capital’s Pfizer PFE Stock Holding History

FORA Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,332	Closed	-$439K	–	656
2025 Q1	$439K	Buy	+17,332	New	+$454K	0.04%	344
2023 Q2	–	Sell	-191,838	Closed	-$7.83M	–	558
2023 Q1	$7.83M	Buy	+191,838	New	+$8.29M	0.78%	25
2021 Q4	–	Sell	-70,438	Closed	-$3.03M	–	425
2021 Q3	$3.03M	Buy	+70,438	New	+$3.12M	0.76%	31
2021 Q1	–	Sell	-17,076	Closed	-$629K	–	1022
2020 Q4	$629K	Buy	+17,076	New	+$626K	0.1%	237
2020 Q2	–	Sell	-72,590	Closed	-$2.25M	–	1213
2020 Q1	$2.25M	Buy	72,590 +2,107	+3%	+$71.8K	0.49%	39
2019 Q4	$2.62M	Buy	+70,483	New	+$2.51M	0.26%	88

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

FORA Capital's PFE Position: Q2 2025 in Review

FORA Capital sold out of Pfizer (PFE) in Q2 2025, closing a stake of 17,332 shares — an estimated $439K sold.

FORA Capital first reported a position in PFE in Q4 2019 and held it in 6 quarters. The position peaked at $7.83M in Q1 2023. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

FORA Capital reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
FORA Capital sold 17,332 Pfizer shares in Q2 2025, an estimated $439K.
FORA Capital first reported a position in Pfizer in Q4 2019 and held it in 6 quarters.
FORA Capital's Pfizer position peaked at $7.83M in Q1 2023.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.